SEARCH

SEARCH BY CITATION

References

  • 1
    Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 4961.
  • 2
    Dahlbäck B. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 143.
  • 3
    Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 28727.
  • 4
    Heeb MJ, Rosing J, Bakker HM, Ternandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91: 272832.
  • 5
    Hackeng TM, Van‘t Veer C, Meijers JCM, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factor Va and Xa. J Biol Chem 1994; 269: 210518.
  • 6
    Makris M, Leach M, Beauchamp N, Daly M, Cooper P, Hampton K, Bayliss P, Peake I, Miller G, Preston F. Gene analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000; 95: 193541.
  • 7
    Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, Lind B, Mannhalter C, Pabinger I, Peitsma PH, Farmstone C, Cooper DN, Saito H, Suzuki K, Bernardi E, Aiach M. Protein S deficiency: a database of mutation – summary of the first update. Thromb Haemost 2000; 84: 918.
  • 8
    Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med 1992; 326: 8006.
  • 9
    Saller F, Villoutreix BO, Amelot A, Kaabache T, Le Bonniec BF, Aiach M, Gandrille S, Borgel D. The γ-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding. Blood 2005; 105: 12230.
  • 10
    Dahlbäck B, Hidebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 1990; 265: 812735.
  • 11
    He X, Shen L, Villoutreix BO, Dahlbäck B. Amino acid residues in thrombi-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem 1998; 273: 2744958.
  • 12
    Giri TK, Villoutreix BO, Wallqvist A, Dahlbäck B, García de Frutos P. Topological studies of the amino terminal modules of vitamin K-dependent protein S using monoclonal antibody epitope mapping and molecular modeling. Thromb Haemost 1998; 80: 798804.
  • 13
    Dahlbäck B. Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. J Biol Chem 1986; 261: 120227.
  • 14
    Dahlbäck B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 1981; 78: 25126.
  • 15
    Mannucci PM, Valsecchi C, Krashmalnicoff A, Faioni EM, Tripodi A. Familial dysfunction of protein S. Thromb Haemost 1989; 62: 7636.
  • 16
    Zöller B, García de Frutos P, Dahlbäck B. Evaluation of the relation between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 352431.
  • 17
    Simmonds RE, Zöller B, Ireland H, Thompson E, García de Frutos P, Dahlbäck B, Lane DA. Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood 1997; 89: 436470.
  • 18
    Rezende SM, Simmonds RE, Lane DA. Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b protein complex. Blood 2004; 103: 1192201.
  • 19
    Yamazaki T, Katsumi A, Kagami K, Okamoto Y, Sugiura I, Hamaguchi M, Kojima T, Takamatsu J, Saito H. Molecular basis of a hereditary type I protein S deficiency caused by a substitution of Cys for Arg474. Blood 1996; 87: 464350.
  • 20
    Espinosa-Parrilla Y, Yamazaki T, Sala N, Dahlbäck B, García de Frutos P. Protein S secretion differences of missense mutations account for phenotypic heterogeneity. Blood 2000; 95: 1739.
  • 21
    Tsuda H, Urata M, Tsuda T, Wakiyama M, Iida H, Nakahara M, Kinoshita S, Hamasaki N. Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency effects on secretion and anticoagulant activity of protein S. Thromb Res 2002; 105: 2339.
  • 22
    Okada H, Takagi A, Murate T, Adachi T, Yamamoto K, Matsushita T, Takamatsu J, Sugita K, Sugimoto M, Yoshioka A, Yamazaki T, Saito H, Kojima T. Identification of protein Sα gene mutations including four novel mutations in eight unrelated patients with protein S deficiency. Br J Haematol 2004; 126: 21925.
  • 23
    Kojima T, Tanimoto M, Kamiya T, Obata Y, Takahashi T, Ohno R, Kurachi K, Saito H. Possible absence of common polymorphisms in coagulation factor IX gene in Japanese subjects. Blood 1987; 69: 34952.
  • 24
    Iwaki T, Matsushita T, Kobayashi T, Yamamoto K, Nomura Y, Kagami K, Nakayama T, Sugiura I, Kojima T, Takamatsu J, Kanayama N, Saito H. DNA sequence analysis of protein S deficiency identification of four point mutation in twelve Japanese subjects. Semin Thromb Hemost 2001; 27: 15560.
  • 25
    Higuchi R. Recombinant PCR. In: InnisMA, GelfandDH, SninskyJJ, WhiteTJ, eds. PCR Protocols. San Diego, CA: Academic Press, 1990: 17783.
  • 26
    Whitt M. Liposome-mediated transfection. In: AusubelFM, BrentR, KingstonRE, MooreDD, SeidmanJG, SmithJA, StruhlK, eds. Current Protocols in Molecular Biology. Cambridge, MA, USA: Wiley, 1991: 9.4.14.
  • 27
    Giri TK, García de Frutos P, Yamazaki T, Villoutreix BO, Dahlbäck B. In vitro characterisation of two naturally occurring mutations in the thrombin-sensitive region of anticoagulant protein S. Thromb Haemost 1999; 82: 162733.
  • 28
    Souri M, Koseki-Kouno S, Iwata H, Kemkes-Matthes B, Ichinose A. A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency. Blood 2005; 105: 314954.
  • 29
    Hackeng TM, Yegneswaran S, Johnson AE, Griffin JH. Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S. Biochem J 2000; 349: 75764.
  • 30
    He X, Shen L, Dahlbäck B. Expression and functional characterization of chimeras between human and bovine vitamin-K-dependent protein-S-defining modules important for the species specificity of the activated protein C cofactor activity. Eur J Biochem 1995; 227: 43340.
  • 31
    Mille-Baker B, Rezende SM, Simmonds RE, Mason PJ, Lane DA, Laffan MA. Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity. Blood 2003; 101: 14168.
  • 32
    Villoutreix BO, García de Frutos P, Lovenklev M, Linse S, Fernalund P, Dahlbäck B. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins 1997; 29: 47891.
  • 33
    Dahlbäck B, Hildebrand B, Linse S. Novel type of very high affinity calcium-binding sites in β-hydroxyasparagine containing epidermal growth factor-like domains in vitamin K-dependent protein S. J Biol Chem 1990; 265: 184819.
  • 34
    Nyberg P, Dahlbäck B, García de Frutos P. The SHBG-like region of protein S is crucial for factor V-dependent APC-cofactor function. FEBS Letts 1998; 433: 2832.